To establish a human hepatic cell line for a convenient reporter gene assay of arylhydrocarbon receptor (AhR) activators, the chimera plasmid containing xenobiotic responsible element (XRE), minimal SV40 promoter, and luciferase reporter gene and the expression vector pRC/CMV containing a neomycin-resistant gene were co-transfected into a human hepatoma cell line, HepG2. Then, antibiotic (G418)-resistant HepG2 cells were selected and cloned. A cell clone, HepG2-A10, showed the highest responsibility to 3-methylcholanthrene (MC)-mediated induction of luciferase among the clones obtained. Expression levels of luciferase activity in HepG2-A10 cells were increased in a dose-and time-dependent manner by treatment with either MC, an AhR-ligand type activator, or omeprazole (OME), a non-AhR ligand type activator. In addition, expression levels of cytochrome P4501A subfamily genes (CYP1A1 and CYP1A2) were also increased in a dose-and time-dependent manner by treatment with MC. The presentˆndings demonstrate that a newly established human HepG2-A10 is a useful cell line for a convenient reporter gene assay of AhR activators.
Introduction
Arylhydrocarbon receptor (AhR) exists in a cytosol as an inactive form, which is a complex with heat shock protein 90 (Hsp90). The AhR is activated through release from Hsp90 by AhR activators, moves into a nucleus, and forms a complex with nuclear AhR nuclear translocator (ARNT). The resultant AhR/ARNT complex binds to a xenobiotic responsible element (XRE) in 5?-upstream of the genes, including cytochrome P4501 (CYP1) family genes, and consequently activates the genes (1) .
CYP1 family genes code the drug-metabolizing enzyme proteins such as CYP1A1 and CYP1A2, and these enzymes are responsible for not only the detoxiˆ-cation of xenobiotics but also metabolic activation of carcinogens including arylhydrocarbons (2, 3) and aromatic amines (4) (5) (6) . Interestingly, there are species-, strain-, and sex-diŠerences in induction of CYP1A subfamily enzyme(s) among experimental animals, and the diŠerences are closely correlated with those in their carcinogenic susceptibilities (4) (5) (6) . Furthermore, incidences of the carcinogenesis and endocrine disruption by AhR activators, such as arylhydrocarbons and dioxins, are known to be lower in AhR-null mice than the wild-type mice (7) (8) (9) (10) .
Species-diŠerences between humans and experimental rodents in characteristics of AhR and AhR-activation pathway are also known. For example, indirubin induces more e‹ciently AhR-dependent transactivation of reporter gene in the yeast expressing human AhR than in the yeast expressing mouse AhR (11) . Then, omeprazole (OME), a benzimidazole derivative, which indirectly activates AhR and consequently up-regulates an expression of CYP1 family genes (12, 13) , induces more e‹ciently the gene expression in human hepatocytes than in rodent hepatocytes (14, 15) . Therefore, to precisely detect AhR activators for humans, establishment of a convenient method with a human cell line is necessary. However, there are few cell lines established for such purpose (16) (17) (18) .
Recently, we have established a rat hepatic cell line KanR2-XL8 for a convenient reporter gene assay of AhR activators (19) . In the present study, we further tried to establish a human cell line for the reporter gene assay of AhR activators and succeeded in the establishment. 
Materials and Methods
Chemicals: 3-Methylcholanthrene (MC), omeprazole (OME), and dimethylsulfoxide (DMSO) were purchased from Sigma (St. Louis, MO, USA). G418 was obtained from Invitrogen (Garlsbad, CA, USA). Reporter Lysis BuŠer was purchased from Promega (Madison, WI, USA). PicaGene Luminscence Reagent was obtained from NipponGene (Toyama, Japan).
Stable transfection of reporter plasmid: A human hepatoma cell line HepG2 was cultured in Dulbecco's modiˆed Eagle's medium (DMEM) supplemented with 5z FCS and used as a host cell. The reporter plasmid XRE-Luc (19) and the neomycin-resistant plasmid pRC/CMV (Invitrogen) were co-transfected into HepG2 cells by use of Lipofectamine reagent (Invitrogen). After 48 h, transfection e‹ciency of a reporter plasmid XRE-Luc was ascertained by the luciferase assay as described in the``Luciferase Assay'' section. HepG2 cells with a reporter plasmid were selected and then, cloned after the 3-week-incubation in the DMEM supplemented with 5z FCS and G418 (400 mg/mL). Ten cell clones with a reporter plasmid XRE-Luc were obtained. In addition, sequence of an XRE region in the plasmid XRE-Luc is compared with those in the plasmids constructed by other investigators (Table 1) .
Luciferase assay: Luciferase assay was performed according to the method as previously described (19) . In brief, XRE-Luc-integrated HepG2 clones were seeded into a 24-well plate (5×10 4 cells/well), cultured for 48 h, and treated with MC or OME for the indicated times. Thereafter, 1×Reporter Lysis BuŠer (100 mL) was added to each well. After 15 min, the resultant cell lysates were frozen at -809 C for 30 min, thawed at room temperature, and centrifuged at 20,000 g for 5 min. The protein concentration in the resultant supernatant was measured with a BCA-protein Assay Kit (Pierce, Rockford, IL, USA) and adjusted to 1 mg protein per mL with phosphate-buŠered saline (pH 7.4). A portion (10 mL) of the supernatant was mixed with 50 mL of PicaGene Luminescence Reagent, and amount of light product was immediately measured with a Luminescencer-PSN (ATTO, Tokyo, Japan). Luciferase activity was represented as a luminescence unit per mg protein. A cell clone, HepG2-A10, which showed the highest responsibility to MC-mediated induction of luciferase among the ten clones, was selected and used for further experiments.
RT-PCR analysis: RT-PCR was performed according to the method as previously described (19) . Brie‰y, HepG2-A10 cells were incubated in the medium containing MC for the indicated times. After the chemical treatment, total RNA was isolated from the cells with Isogen (NipponGene). A portion (4 mg) of total RNA was converted to cDNA using poly d(N)6 primer (Pharmacia Biotech, Piscataway, NJ, USA) and MMLV Reverse Transcriptase (Invirogen) in an RT reaction mixture (20 mL). PCR was performed in a total reaction mixture (25 mL) containing RT reaction mixture (0.8 mL), the corresponding primer sets (12.5 pmol), and 0.625 unit of AmpliTaq Gold TM (Applied Biosystems, Norwalk, CT, USA).
The primer sets used for determinations of expression levels of the target genes were as follows: CYP1A1, protocol consisted of the preactivation of AmpliTaq Gold TM for 10 min at 959 C, 16-35 cycles of denaturation for 30 sec at 959 C, annealing for 30 sec at 559 C for CYP1A1 and CYP1A2 or 609 C for GAPDH, and the elongation for 1 min at 729 C with a GeneAmp PCR system model 9600 (Perkin-Elmer Norwalk, CT, USA). The resultant PCR products were separated by an agarose-gel electrophoresis and visualized by ethidium bromide staining under UV light. Amount of each PCR product was densitometrically quantiˆed with a computer using Kodak 1D Image Analysis Software (Macintosh 1D version 2.02). Expression level of each gene was normalized to that of GAPDH.
Results
Establishment of human hepatic cell lines for screening of AhR activators: The reporter plasmid XRE-Luc (19) and the pRC/CMV vector containing the neomycin-resistant gene were co-transfected into a human hepatoma cell line HepG2, and thereafter, G418-resistant 10 clones stably expressing a luciferase reporter gene were obtained. Among the 10 clones, a clone HepG2-A10 was selected as the most responsive clone to MC-mediated induction of luciferase reporter gene (data not shown) and used for further experiments.
MC-mediated induction of luciferase: A timedependency for MC-mediated induction of luciferase was examined in HepG2-A10 cells (Fig. 1A) . The cells were treated with MC at 10 -6 M, and the luciferase activities were measured at 3, 6, 12 and 24 h later. Signiˆcant increase in luciferase activity was observed even at 3 h later. The increase occurred in a time-dependent manner up to 12 h, and thereafter, the increased level was retained up to 24 h.
A concentration-dependency for the induction of luciferase by MC was further examined. When luciferase activity was measured at 6 h after the chemical treatment, it increased in a concentrationdependent manner over a range from 10 -8 M to 10 -6 M (Fig. 1B) .
MC-mediated activation of AhR-regulated genes: As AhR-regulated genes, CYP1A subfamily genes, CYP1A1 and CYP1A2, were selected, and culture period-dependent changes in the expression of the genes after treatment with MC were examined by RT-PCR in HepG2-A10 cells. Representative expression patterns of CYP1A subfamily genes after the MC treatment were shown in Fig. 2A .
In the cells treated with MC at a concentration of 10
M, clear increases in expression levels of the CYP1A subfamily genes occurred within 1 h, and their levels reached at a maximum 6 h later. Thereafter, gene expression levels of CYP1A1 and CYP1A2 were gradually reduced (Fig. 2B ). In addition, although culture period-dependent increases in the expression of the CYP1A subfamily genes were also observed in HepG2-A10 cells treated with a vehicle alone (control), their increased levels were much lower than those in MCtreated cells at the corresponding culture periods (data not shown). Subsequently, concentration eŠects of MC on the expression of CYP1A subfamily genes were examined at 6 h after the chemical treatment. Representative expression patterns and levels of CYP1A subfamily genes after MC treatment were shown in Figs. 3A and 3B, respectively. Expression levels of the CYP1A1 and CYP1A2 genes were linearly increased in a concentration-dependent manner over a range from 10 -9 M to 10 -7 M. In addition, no signiˆcant change in expression level of the GAPDH gene was observed at any concentrations of MC examined.
Responsibility of HepG2-A10 cells toward a non- RT-PCR products from four individual samples in each experimental group were mixed, and the mixture was subjected to agarose gel-electrophoresis (A). The values in parentheses represent the number of PCR cycles performed. Expression levels of the CYP1A1 and CYP1A2 genes were measured using four individual samples in each experimental group, calculated on the basis of that of the GAPDH, and represented as ratios to the corresponding controls (B). The data shown represent mean±SD in each experimental group (n＝4). *Signiˆcant diŠerences (pº0.01) from the corresponding controls assayed by ANOVA and Dunnett's test. Fig. 3 . Concentration-dependent changes in the expression of CYP1A1 and CYP1A2 after treatment of HepG2-A10 cells with MC. HepG2-A10 cells were treated with the indicated concentrations of MC for 6 h. Total RNA was prepared from MC-treated cells and used for RT-PCR analysis. RT-PCR products from four individual samples in each experimental group were mixed, and the mixture was subjected to agarose gel-electrophoresis (A). The values in the parentheses (Fig. 3A) represent the number of PCR cycles performed. The expression levels of CYP1A1 and CYP1A2 were measured using four individual samples in each experimental group, calculated on the basis of that of the GAPDH, and compared to the corresponding controls (B). The data represent mean±SD in each experimental group (n＝4). *Signiˆcant diŠerences (pº0.01) from the corresponding controls assayed by ANOVA and Dunnett's test. Fig. 4 . Time-and concentration-dependent inductions of luciferase activity after treatment of HepG2-A10 cells with OME. HepG2-A10 cells were treated with OME (10 -4 M) for the indicated times (A) or at the indicated concentrations of OME for 24 h (B), and the luciferase activity was measured as described in``Materials and Methods''. The values of luciferase activities shown are the ratios to a maximum luciferase activity in each experiment group (A or B). The data represent mean±SD in each experimental group (n＝4). * Signiˆcant diŠerences (pº0.01) from the corresponding controls assayed with ANOVA and Dunnett's test.
ligand type AhR activator: OME, a non-ligand type AhR activator (12, 13) , shows species-diŠerence in AhR activation between humans and rodents (14, 15) . Therefore, we examined whether or not OME-mediated induction of luciferase occurs in HepG2-A10 cells.
Treatment of HepG2-A10 cells with OME (10 -4 M) led to induction of luciferase activity in a culture perioddependent manner over a range from 12 h to 24 h (Fig. 4A) . Furthermore, a concentration-dependency for the induction of luciferase was examined at 24 h after treatment with OME. The OME-mediated induction occurred in a concentration-dependent manner over a range from 10 -5 M to 10 -4 M (Fig. 4B) .
Discussion
In the present study, we succeeded in establishment of a cell line HepG2-A10, which showed the highest responsibility to AhR activators among the established 10 clones stably expressing luciferase gene, by transfection into a human hepatoma cell line HepG2 of a chimera plasmid (XRE-Luc) (19) . As AhR-regulated genes, CYP1A subfamily genes such as CYP1A1 and CYP1A2 were selected, and changes in their gene expression levels after treatment of MC, an AhR-ligand type activator (1), were examined. MC-mediated increases in expression levels of luciferase and AhRregulated CYP1A subfamily genes were observed in a time-and concentration-dependent manner. However, there were slight diŠerences in MC-induced expression patterns of the CYP1A1/1A2 genes and luciferase. These diŠerences would be dependent on those in stability (a half-life) between luciferase and CYP1A1/1A2 mRNAs. Namely, luciferase would be more stable than the CYP1A mRNAs. In addition, similar diŠerences in MC-induced expression patterns of the CYP1A1 gene and luciferase are also observed in a rat KanR2-XL8 cell line (19) .
Induction of luciferase by OME, a non-ligand type AhR activator (12, 13) , was also observed in HepG2-A10. Thus, a newly established HepG2-A10 resembles the reported human cell lines, 101L (16) and DRE12.6 (18), in responsibility for AhR activators such as MC and OME. This suggests that only existence of the AhRbinding core sequence (5?-CACGC-3? or 5?-GCGTG-3?) in their plasmid XRE regions is important for the AhRmediated induction of luciferase, because with an exception of the core sequence, sequences of the XRE regions diŠer among HepG2-A10, 101L, and DRE12.6 cell lines (Table 1) .
To date, pGudLuc1.1 (22) and pL1A1N (16) reporter plasmids, which contain the mouse CYP1A1 promoter (-1301/-849) and human CYP1A1 promoter (-1612/＋292), respectively, are widely used for construction of the cell lines for the detection of AhR activators. However, these promoter regions contain the binding sequences for transcription factors such as peroxisome proliferator-activated receptor a (23), retinoic acid receptor a (24), and/or nuclear factor-1 (25) , which might contribute to gene expression of CYP1A1. Therefore, the cell line with a plasmid containing the CYP1A1 promoter might not be adequate for screening of AhR-selective activators. On the other hand, the plasmid``XRE-Luc'' used in the present experiment contains only XRE region, and HepG2-A10 with the plasmid would be more adequate for screening of AhR-selective activators than the reported cell lines.
In conclusion, we newly established a human hepatoma cell line HepG2-A10 useful for a convenient reporter gene assay of AhR activators. Further studies with both human HepG2-A10 and rat KanR2-XL8 cell lines, which are established by transfection of a plasmid`X RE-Luc'', would contribute to not only screening of AhR activators but also understanding of species-diŠer-ences in an AhR activation pathway.
